Inquiry Basket
Services Details
What are Cholesterol-siRNA Conjugates?
Cholesterol-siRNA conjugates belong to lipophilic siRNA derivates.
Cholesterol is one of the most well-studied lipid moieties. It's the part of membrane as it contains 15%-30% of cellular membranes and it is also transported into cells by LDL and HDL, which bind to corresponding receptors. So cholesterol-siRNA can bind to LDL and HDL effectively. Cholesterol was conjugated to the 3′-terminus of the sense strand of siRNA via a pyrrolidone linkage. So cholesterol-siRNA conjugate can dramatically improve the pharmacokinetic properties of siRNA, like half-life and bioavailability in serum.
Figure 1. The structure of cholesterol (CAS No. 57-88-5)
Cholesterol-siRNA conjugates were more effectively retained in the body compared with other lipophilic conjugates. Cholesterol-siRNA conjugate accumulated in almost all organs, and most effectively in the liver, adrenal glands, spleen and skin, following subcutaneous injection.
There are many cholesterol-siRNA conjugates which are at the clinical trial stage. Cholesterol-siRNA conjugate RXI-109 by PXi Pharmaceuticals was under Phase II clinical studies for its ability to reduce hypertrophic scarring. RXI-109 targets connective tissue growth factor. RXI-109 was also evaluated in a Phase I/II trial in the eyes of age-related macular degeneration patients at risk for subretinal fibrosis.
BOC Sciences' Cholesterol-siRNA Conjugation Services
We provide cholesterol-siRNA conjugates with high quality. We can design and synthesis the siRNA based on the target gene, and our parent company BOC Sciences can provide high quality cholesterol, we can conjugate them to form cholesterol-siRNA conjugates.
- siRNA design, synthesis, purification, characterization
- Conjugate the cholesterol and siRNA
- Characterization
Why Choose BOC Sciences?
- High quality raw materials
- Free design
- Experienced experts,strict QA and QC
- Advanced analytical equipments
- Professional technical support
- 1 on 1 customer service
- Competitive price
- Fast delivery
Ref:
- Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., … Stoffel, M. (2007). Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology, 25(10), 1149–1157.
- Osborn, M. F., & Khvorova, A. (2018). Improving siRNA Delivery In Vivo Through Lipid Conjugation. Nucleic Acid Therapeutics, 28(3), 128–136.
* Only for research. Not suitable for any diagnostic or therapeutic use.
Online Inquiry
Services
Products
Highlighted Services
GMP Oligonucleotide Manufacturing Service
For more than 15 years, BOC Sciences has been manufacturing oligonucleotides for pre-clinical, pharmaceutical, food safety, and animal health industries. We provide customized and flexible oligonucleotide GMP or non-GMP production services to meet different production needs.
Lipid Nanoparticle(LNP) for RNA Delivery
BOC Sciences offers comprehensive LNP- mRNA delivery services tailored to meet the specific needs of mRNA vaccine development. Our expertise in nanoparticle formulation and mRNA chemistry enables us to design custom LNP formulations optimized for stability, efficacy, and safety.
BOC Sciences promises to offer you with GalNAc-siRNA conjugation services to help you conduct further research on GalNAc-siRNA conjugates and explore their mores omnics capabilities, the working mechanism as well as their potential therapeutic profiles.
BOC Sciences offers aptamer customization services to generate high-quality aptamers tailored to your goals, delivering excellent results even for the most difficult target molecules.
Peptide-Oligonucleotide Conjugation
BOC Sciences is committed to providing our customers with comprehensive modification and labeling, offering affordable custom oligonucleotides or peptide-oligonucleotide conjugates.
